Jaime Bartushak - Nov 7, 2024 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role
Chief Financial Officer
Signature
/s/ Alexander M. Donaldson, by power of attorney
Stock symbol
CTXR
Transactions as of
Nov 7, 2024
Transactions value $
$0
Form type
4
Date filed
11/12/2024, 05:00 PM
Previous filing
Aug 14, 2024
Next filing
Dec 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CTXR Common Stock 60.4K Nov 7, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Stock Option (Right to Purchase Common Stock) Award $0 +350K $0.00 350K Nov 7, 2024 Common Stock 350K $0.38 Direct F1
holding CTXR Stock Option (Right to Purchase Common Stock) 300K Nov 7, 2024 Common Stock 300K $0.70 Direct F2
holding CTXR Stock Option (Right to Purchase Common Stock) 300K Nov 7, 2024 Common Stock 300K $1.25 Direct F3
holding CTXR Stock Option (Right to Purchase Common Stock) 300K Nov 7, 2024 Common Stock 300K $2.04 Direct F4
holding CTXR Stock Option (Right to Purchase Common Stock) 100K Nov 7, 2024 Common Stock 100K $2.00 Direct F4
holding CTXR Stock Option (Right to Purchase Common Stock) 125K Nov 7, 2024 Common Stock 125K $1.01 Direct F4
holding CTXR Stock Option (Right to Purchase Common Stock) 100K Nov 7, 2024 Common Stock 100K $0.67 Direct F4
holding CTXR Stock Option (Right to Purchase Common Stock) 70K Nov 7, 2024 Common Stock 70K $1.62 Direct F4
holding CTXR Stock Option (Right to Purchase Common Stock) 25K Nov 7, 2024 Common Stock 25K $3.45 Direct F4
holding CTXR Stock Option (Right to Purchase Common Stock) 48.3K Nov 7, 2024 Common Stock 48.3K $10.50 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date
F2 The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
F3 The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
F4 The options are vested in full and exercisable immediately.